On the sidelines of the inaugural annual global AlUla Conference for Emerging Market Economies in Al Ula, Saudi Arabia (February 16-17), Saudi Arabia's Finance Ministry and the International Monetary ...

For The SOS Group, the third-party integrations enabling an ecosystem ... Joint Statement by Saudi Finance Minister and IMF Managing Director on Supporting Recovery in the Middle East's ...

Merck (MRK) stock in focus as anti-cancer agent Welireg is approved in the EU for kidney tumor conditions, VHL disease and ...

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

Joint Statement by the Saudi Finance Minister and IMF Managing Director on Supporting Recovery in the Middle East’s Conflict-Affected Economies ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at Leerink Partners believe that Merck’s Winrevair “should have ...

Making acquisitions is one potential back-up plan. Merck bought biotech group Acceleron Pharma for $11.5bn in 2021 and autoimmune disease specialist Prometheus Biosciences for $10.8bn in 2023.

Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...

On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

The IMF's most recent economic outlook projected global growth at 3.3% in 2025. The group expects growth at 2.7% in the US and 1% in the eurozone. Christine Lagarde, speaking alongside Georgieva ...